| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 2022 | Oct 11, 2022 | Outlook Therapeutics, Inc. | Director | Buy | 91.3 | +30,000 | 78.95% | ✗ | $38.7K |
| Dec 2, 2021 | Dec 2, 2021 | Outlook Therapeutics, Inc. | Director | Buy | 91.3 | +18,000 | 90.00% | ✗ | $25.2K |
| Apr 19, 2021 | Apr 20, 2021 | Outlook Therapeutics, Inc. | Director | Buy | 91.3 | +10,000 | 100.00% | ✗ | $18.2K |
| Sep 17, 2020 | Sep 17, 2020 | Outlook Therapeutics, Inc. | Director | Buy | 90.0 | +10,000 | 100.00% | ✗ | $6.7K |